Effect of Mitomycin C on the Size of Antrostomy after Endoscopic Sinus Surgery

Abstract

Objectives:

Mitomycin C (MMC) is an antibiotic-antineoplastic agent that decreases fibroblast proliferation and scar formation. We aimed to evaluate the effect of MMC on the size of antrostomy and the mucociliary clearance rate.

Methods:

We selected 20 patients with chronic sinusitis on both sides. After middle meatal antrostomy, we selected one side, and a piece of Merocel soaked with 1.5 mL of MMC (0.4 mg/mL) was applied for 5 minutes. On the other side, normal saline solution was applied for a control. The size of the antrostomy was measured serially after surgery with a ruler. Mucociliary clearance was assessed by the saccharin test.

Results:

The effect of MMC in maintaining the size of the antrostomy was only significant during the first month. The relative size (the ratio of the remaining antrostomy area compared to the area in the immediate postoperative period) in the first month was significantly greater on the MMC-treated side than on the control side. The results of the saccharin test were not different between the two sides.

Conclusions:

Topical MMC application may have a short-term effect in maintaining the patency of the antrostomy site. However, it does not seem to improve the relative size over an extended period of time.

Keywords

antrostomy mitomycin C

Get full access to this article

View all access options for this article.

References

Elwany

Bassyouni

Morad

. Some risk factors for refractory chronic sinusitis: An immunohistochemical and electron microscopic study. J Laryngol Otol 2002; 116: 112–5.

McMains

Kountakis

. Revision functional endoscopic sinus surgery: Objective and subjective surgical outcomes. Am J Rhinol 2005; 19: 344–7.

Kountakis

Bradley

. Effect of asthma on sinus computed tomography grade and symptom scores in patients undergoing revision functional endoscopic sinus surgery. Am J Rhinol 2003; 17: 215–9.

Chambers

Davis

Cook

Nishioka

Rudman

. Long-term outcome analysis of functional endoscopic sinus surgery: Correlation of symptoms with endoscopic examination findings and potential prognostic variables. Laryngoscope 1997; 107: 504–10.

Davis

Templer

LaMear

. Patency rate of endoscopic middle meatus antrostomy. Laryngoscope 1991; 101: 416–20.

Salam

Cable

. Middle meatal antrostomy: Long-term patency and results in chronic maxillary sinusitis. A prospective study. Clin Otolaryngol Allied Sci 1993; 18: 135–8.

Malki

Quine

Pfleiderer

. Nasal splints, revisited. J Laryngol Otol 1999; 113: 725–7.

Nayak

Balakrishnan

Hazarika

. Prevention and management of synechia in pediatric endoscopic sinus surgery using dental wax plates. Int J Pediatr Otorhinolaryngol 1998; 46: 171–8.

Yanagisawa

Joe

. The use of spacers to prevent postoperative middle meatal adhesions. Ear Nose Throat J 1999; 78: 530–2.

10.

Catalano

Roffman

. Evaluation of middle meatal stenting after minimally invasive sinus techniques (MIST). Otolaryngol Head Neck Surg 2003; 128: 875–81.

11.

Tom

Palasti

Potsic

Handler

Wetmore

. The effects of gelatin film stents in the middle meatus. Am J Rhinol 1997; 11: 229–32.

12.

Gall

Witterick

. The use of middle meatal stents post-endoscopic sinus surgery. J Otolaryngol 2004; 33: 47–9.

13.

You

Fang

. Intraoperative mitomycin C in dacryocystorhinostomy. Ophthal Plast Reconstr Surg 2001; 17: 115–9.

14.

Sires

Tong

Royack

Oda

. Effect of brief exposure to mitomycin C on cultured human nasal mucosa fibroblasts. Ophthal Plast Reconstr Surg 2000; 16: 119–25.

15.

Kao

Liao

Tseng

Chen

Hou

. Dacryocystorhinostomy with intraoperative mitomycin C. Ophthalmology 1997; 104: 86–91.

16.

Selig

Biesman

Rebeiz

. Topical application of mitomycin-C in endoscopic dacryocystorhinostomy. Am J Rhinol 2000; 14: 205–7.

17.

Camara

Bengzon

Henson

. The safety and efficacy of mitomycin C in endonasal endoscopic laser-assisted dacryocystorhinostomy. Ophthal Plast Reconstr Surg 2000; 16: 114–8.

18.

Chung

Cosenza

Rahbar

Metson

. Mitomycin C for the prevention of adhesion formation after endoscopic sinus surgery: A randomized, controlled study. Otolaryngol Head Neck Surg 2002; 126: 468–74.

19.

Anand

Tabaee

Kacker

Newman

Huang

. The role of mitomycin C in preventing synechia and stenosis after endoscopic sinus surgery. Am J Rhinol 2004; 18: 311–4.

20.

Lund

MacKay

. Staging in rhinosinusitis. Rhinology 1993; 31: 183–4.

21.

Ingrams

Volk

Biesman

Pankratov

Shapshay

. Sinus surgery: Does mitomycin C reduce stenosis?. Laryngoscope 1998; 108: 883–6.

22.

Musy

Kountakis

. Anatomic findings in patients undergoing revision endoscopic sinus surgery. Am J Otolaryngol 2004; 25: 418–22.

23.

Ramadan

. Surgical causes of failure in endoscopic sinus surgery. Laryngoscope 1999; 109: 27–9.

24.

Albu

Tomescu

. Small and large middle meatus antrostomies in the treatment of chronic maxillary sinusitis. Otolaryngol Head Neck Surg 2004; 131: 542–7.

25.

Nouraei

Hajioff

Almeyda

Saleh

. Measurement of absolute dimensions in endoscopic sinus surgery. Laryngoscope 2005; 115: 889–93.

26.

Yeatts

Neves

. Use of mitomycin C in repeat dacryocystorhinostomy. Ophthal Plast Reconstr Surg 1999; 15: 19–22.

27.

Rahbar

Shapshay

Healy

. Mitomycin: Effects on laryngeal and tracheal stenosis, benefits, and complications. Ann Otol Rhinol Laryngol 2001; 110: 1–6.

28.

Ugurbas

Zilelioglu

Sargon

Anadolu

Akiner

Akturk

. Histopathologic effects of mitomycin-C on endoscopic transnasal dacryocystorhinostomy. Ophthalmic Surg Lasers 1997; 28: 300–4.

29.

Asai

Haruna

Otori

Yanagi

Fukami

Moriyama

. Saccharin test of maxillary sinus mucociliary function after endoscopic sinus surgery. Laryngoscope 2000; 110: 117–22.